Hoyoung Huh - Nov 14, 2024 Form SCHEDULE 13G Schedule Report for Akari Therapeutics, Plc (AKTX)

Filing Manager: Huh Hoyoung
Reporting Manager: Hoyoung Huh, M.D., Ph.D.
Security: Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value
Symbol: AKTX
Shares outstanding: 53.5B shares
Disclosed Ownership: 8.29B shares
Ownership: 15.5%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 05:00 PM
Date of event: Nov 14, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Hoyoung Huh, M.D., Ph.D.	15.5%	8.29B	8.29B	0	/s/ Hoyoung Huh	Authorized Person